latest news releases from the newsroom
Atlas Copco Completes Electric Tools Sale
STOCKHOLM, Sweden, Nov. 2, 2005 (PRIMEZONE) -- Atlas Copco AB and Techtronic Industries Co. Ltd. have reached an agreement in respect of the final closing balance in the electric tool deal. The result for Atlas Copco AB is a total gain of MSEK 200, net after selling expenses and taxes, which will be recorded during the 4th quarter as net profit on discontinued operations.
Leading Global Communications Company Invests $1.4 M in Telelogic TAU
MALMO, Sweden, Nov. 02, 2005 (PRIMEZONE) -- Leading global communications company invests US$1.4 M in Telelogic TAU: A core component of Telelogic Enterprise Life Cycle Solution, Telelogic TAU G1 and TAU G2 is selected for UML Model Driven Development of Software and Testing by leading communications company.
Calypso Wireless, Inc.
Calypso Wireless Received Purchase Order for Over US$ 2 Million from Servinova, a Cisco Systems Registered Partner Company, for the Delivery of its C1250i Dual Mode Wi-Fi-GSM-GPRS VoIP Cellular Phone Connecting With Skype for Long Distance Calls
MIAMI LAKES, Fla., Nov. 2, 2005 (PRIMEZONE) -- Calypso Wireless, Inc. (Pink Sheets:CLYW), a leader in advanced wireless telecommunications technology, announced today that it has received a purchase order for US$ 2.02 million from Servinova, a Cisco Systems registered partner company, for the delivery of the Calypso C1250i Dual Mode ASNAP(tm) patented technology (U.S. Patent number 6,680,923) Wi-Fi-GSM-GPRS VoIP cellular phone, which runs on Intel PXA series application processor and Microsoft WinCE 5.0 operating system.
Saab and TietoEnator Create Joint Venture in Finland
LINKOPING, Sweden, Nov. 2, 2005 (PRIMEZONE) -- Saab and TietoEnator will form a Joint Venture called TietoSaab Systems Oy aiming at becoming a major supplier in defence and civil security solutions in Finland. Thereby Saab will also get access to a long term IT Support from TietoEnator.
Crucell Teams up with ACE BioSciences and Harvard to Accelerate Bacterial Antibody Program
LEIDEN, Netherlands, Nov. 02, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has licensed bacterial antigens from ACE BioSciences A/S and the Brigham and Women's Hospital, a teaching hospital of Harvard Medical School, to accelerate its bacterial antibody discovery program. The bacterial surface antigens licensed have been validated for therapeutic efficacy in appropriate animal models for bacterial disease.